Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors. | Biology (Basel) | 2023 | 36829496 | PubTator, text mining | PubMed |
| Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. | Curr Oncol | 2023 | 36826113 | PubTator, text mining | PubMed |
| Immunotherapeutic Approaches in Ovarian Cancer. | Curr Issues Mol Biol | 2023 | 36826026 | PubTator, text mining | PubMed |
| Analysis of bulk RNA-seq data from sepsis patients reveals sepsis-associated lncRNAs and targeted cell death-related genes contributing to immune microenvironment regulation. | Front Immunol | 2023 | 36817490 | PubTator, text mining | PubMed |
| Roles of TGF‑β signalling pathway‑related lncRNAs in cancer (Review). | Oncol Lett | 2023 | 36817052 | PubTator, text mining | PubMed |
| M6A Promotes Colorectal Cancer Progression via Regulating the miR-27a-3p/BTG2 Pathway. | J Oncol | 2023 | 36816363 | PubTator, text mining | PubMed |
| Evaluation of Apoptosis, Cell Proliferation and Cell Cycle Progression by Inactivation of the NEAT1 Long Noncoding RNA in a Renal Carcinoma Cell Line Using CRISPR/Cas9. | Iran J Biotechnol | 2023 | 36811109 | PubTator, text mining | PubMed |
| Metastasis-Related Signature for Clinically Predicting Prognosis and Tumor Immune Microenvironment of Osteosarcoma Patients. | Mol Biotechnol | 2023 | 36807122 | PubTator, text mining | PubMed |
| MicroRNA-122 in human cancers: from mechanistic to clinical perspectives. | Cancer Cell Int | 2023 | 36803831 | PubTator, text mining | PubMed |
| Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer. | Heliyon | 2023 | 36798768 | PubTator, text mining | PubMed |
| Long non-coding RNA signature in colorectal cancer: research progression and clinical application. | Cancer Cell Int | 2023 | 36797749 | PubTator, text mining | PubMed |
| Targeting epigenetic regulators to overcome drug resistance in cancers. | Signal Transduct Target Ther | 2023 | 36797239 | PubTator, text mining | PubMed |
| Long noncoding RNA ENST00000436340 promotes podocyte injury in diabetic kidney disease by facilitating the association of PTBP1 with RAB3B. | Cell Death Dis | 2023 | 36792603 | PubTator, text mining | PubMed |
| SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways. | Open Med (Wars) | 2023 | 36785765 | PubTator, text mining | PubMed |
| Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer. | Front Pharmacol | 2023 | 36778005 | PubTator, text mining | PubMed |
| Influence of Butyrate on Impaired Gene Expression in Colon from Patients with High Blood Pressure. | Int J Mol Sci | 2023 | 36768972 | PubTator, text mining | PubMed |
| Non-Coding RNAs Regulating Mitochondrial Functions and the Oxidative Stress Response as Putative Targets against Age-Related Macular Degeneration (AMD). | Int J Mol Sci | 2023 | 36768958 | PubTator, text mining | PubMed |
| UPF1-From mRNA Degradation to Human Disorders. | Cells | 2023 | 36766761 | PubTator, text mining | PubMed |
| Recent Updates on Corticosteroid-Induced Neuropsychiatric Disorders and Theranostic Advancements through Gene Editing Tools. | Diagnostics (Basel) | 2023 | 36766442 | PubTator, text mining | PubMed |
| Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy. | Cancers (Basel) | 2023 | 36765947 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=24